Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Navicyte Inc
Profile last edited on: 1/30/2017      CAGE:       UEI:

Business Identifier: Pharmacokinetics and screening technology
Year Founded
1996
First Award
1997
Latest Award
1997
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2150 Brooksboro Circle
Reno, NV 89509
   N/A
   grass@navicyte.com
   N/A
Location: Single
Congr. District: 02
County: Washoe

Public Profile

NaviCyte Inc specialized in drug selection through its in-vitro screening capability and PK-Informatics tools. Per a transaction published in late November 1998, in a stcok-cash deal, NaviCyte became a wholly-owned subsidiary of Trega Biosciences, Inc. (Nasdaq: TRGA) and was expected to relocate its operations from Sparks, Nevada, to Trega's facility in San Diego

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$99,995
Phase II Dollars
$0
Total Awarded
$99,995

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1997 1 NIH $99,995
Project Title: In Vitro Device For Cell Culture Based Screening

Key People / Management

  George Grass

  Patrick Sinko -- Chief Scientific Officer & Co-Founder

Company News

Nov 13 1998
Trega Biosciences Announces Acquisition of NaviCyte, Inc.